Zymergen Statistics
Share Statistics
Zymergen has 0
shares outstanding. The number of shares has increased by 2.81%
in one year.
| n/a |
| 2.81% |
| 0.72% |
| n/a |
| 73.21M |
| n/a |
| n/a |
Short Selling Information
The latest short interest is 3.58M, so 0% of the outstanding
shares have been sold short.
| 3.58M |
| n/a |
| 5.73% |
| 4.85 |
Valuation Ratios
The PE ratio is -1.37 and the forward
PE ratio is null.
Zymergen's PEG ratio is
-0.02.
| -1.37 |
| n/a |
| 29.69 |
| n/a |
| 1.22 |
| -1.48 |
| -0.02 |
Financial Ratio History Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Zymergen.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 5.54,
with a Debt / Equity ratio of 0.11.
| 5.54 |
| 5.46 |
| 0.11 |
| -0.13 |
| -0.13 |
| -23.6 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $33.35K |
| $-720.69K |
| 502 |
| 0.03 |
| 11.55 |
Taxes
| 51K |
| -0.01% |
Stock Price Statistics
The stock price has increased by 0% in the
last 52 weeks. The beta is 0, so Zymergen's
price volatility has been lower than the market average.
| 0 |
| n/a |
| 2.65 |
| 2.77 |
| 43.91 |
| 1,041,782 |
Income Statement
In the last 12 months, Zymergen had revenue of 16.74M
and earned -361.79M
in profits. Earnings per share was -4.87.
| 16.74M |
| -52.98M |
| -347.03M |
| -361.79M |
| -326.33M |
| -346.5M |
| -4.87 |
Full Income Statement Balance Sheet
The company has 386.11M in cash and 43.95M in
debt, giving a net cash position of 342.15M.
| 386.11M |
| 43.95M |
| 342.15M |
| -1.14B |
| n/a |
| n/a |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -302.46M
and capital expenditures -33.44M, giving a free cash flow of -335.9M.
| -302.46M |
| -33.44M |
| -335.9M |
| -4.52 |
Full Cash Flow Statement Margins
Gross margin is -316.42%, with operating and profit margins of -2072.68% and -2160.81%.
| -316.42% |
| -2072.68% |
| -2160.51% |
| -2160.81% |
| -1949.08% |
| -2072.68% |
| -2006.24% |